Type 2 Diabetic Neuropathy in the GLP-1 Era
GLP-1 receptor agonists have substantially reshaped the therapeutic landscape for type 2 diabetes and obesity, and the indications now being pursued...
diabetes
Modeling diabetic neuropathy with mechanistic and translational considerations
Diabetic neuropathy affects nearly half of individuals living with diabetes, yet its underlying biological drivers remain only partially defined....
In Vitro Modeling
The goal of the preclinical development process is to help predict clinical efficacy, emphasizing the importance of studying diseases through models...